A Fresh Look for an Established Biotech

Turning Point Therapeutics

Public Relations

Communication activities included relationship-building with industry influencers, thought leadership opportunities and media coverage in top-tier, business, biotech trades, oncology trades and regional outlets. Turning Point Therapeutics increased their share of voice and was one of the best-performing biotech stocks in 2019.


Informed by a positioning workshop, CanaleComm rebranded Turning Point Therapeutics, capturing their legacy while adding their laser-sharp focus on the cancer treatment paradigm.


Using a sleek, modern design with echoes of its updated logo, Turning Point’s new corporate website reflects the company’s essence and mission—a rapidly growing biopharma company using novel science to target genetic drivers of cancer and circumvent treatment resistance.


Canale Communications ©2021